CD20+ Aggressive B-Cell Lymphoma
1 clinical trials · Condition
◉ Watch CD20+ Aggressive B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine (NCT01478542) | Universität des Saarlandes | 2011-11-01 |
Track CD20+ Aggressive B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.